Skip to main content
Erschienen in: Urolithiasis 6/2013

01.11.2013 | Original Paper

Effect of the body mass index on outcomes of flexible ureterorenoscopy

verfasst von: Erhan Sari, Abdulkadir Tepeler, Emrah Yuruk, Berkan Resorlu, Tolga Akman, Murat Binbay, Abdullah Armagan, Ali Unsal, Ahmet Yaser Muslumanoglu

Erschienen in: Urolithiasis | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

The aim of the study to compare outcomes of flexible ureterorenoscopy in patients with different body mass index (BMI) scores and to explore whether the BMI has an effect on outcomes of RIRS. Five hundred and two patients who underwent flexible URS in 3 centers between 2008 and 2012 for the management of single upper urinary tract calculi were retrospectively reviewed. Patients were categorized as normal weight BMI 18.5 to 24.99 kg/m2, overweight 25 to 29.99 kg/m2, obese 30 to 39.99 kg/m2 and morbid obese >40 kg/m2.The groups were assessed in terms of demographic parameters including age, gender, stone size, intraoperative and postoperative variables. The mean patient age was 41.3 ± 15.51 (18–81) years and with an average BMI 26.68 ± 5.2 kg/m2 (16.64–55.15 kg/m²). Of the patients, 43.2 % had normal weight (NW), 32.2 % were overweight (OW), 21.9 % were obese (O) and 2.5 % were morbidly obese (MO). Stone-free rates after single procedure in NW, OW, O, MO groups were 60.8, 61.7, 73.6, 61.5 %, respectively (p = 0.079). Overall targeted stone-free rates were also similar in four groups (88.9, 90.1, 93.6, 90.4 %, p = 0.586). There were no statistically significant differences in the frequency of complications and mean hospitalization time among the groups (p > 0.05). In conclusion, this study demonstrated that flexible URS is a valuable option for the treatment of kidney stone in both obese and non-obese patients. BMI did not influence the postoperative outcomes.
Literatur
1.
Zurück zum Zitat Maalouf NM, Cameron MA, Moe OW et al (2004) Novel insights into the pathogenesis of uric acid nephrolithiasis. Curr Opin Nephrol Hypertens 13:181–189PubMedCrossRef Maalouf NM, Cameron MA, Moe OW et al (2004) Novel insights into the pathogenesis of uric acid nephrolithiasis. Curr Opin Nephrol Hypertens 13:181–189PubMedCrossRef
2.
Zurück zum Zitat Pearle MS (2004) Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. Int Braz J Urol 30:338–339PubMed Pearle MS (2004) Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. Int Braz J Urol 30:338–339PubMed
3.
Zurück zum Zitat Siener R, Glatz S, Nicolay C et al (2004) The role of overweight and obesity in calcium oxalate stone formation. Obes Res 12:106–113PubMedCrossRef Siener R, Glatz S, Nicolay C et al (2004) The role of overweight and obesity in calcium oxalate stone formation. Obes Res 12:106–113PubMedCrossRef
4.
Zurück zum Zitat Calvert RC, Burgess NA (2005) Urolithiasis and obesity: metabolic and technica considerations. Curr Opin Urol 15:113–117PubMedCrossRef Calvert RC, Burgess NA (2005) Urolithiasis and obesity: metabolic and technica considerations. Curr Opin Urol 15:113–117PubMedCrossRef
5.
Zurück zum Zitat Duffey BG, Pedro RN, Kriedberg C et al (2008) Lithogenic risk factors in the morbidly obese population. J Urol 179:1401–1406PubMedCrossRef Duffey BG, Pedro RN, Kriedberg C et al (2008) Lithogenic risk factors in the morbidly obese population. J Urol 179:1401–1406PubMedCrossRef
6.
Zurück zum Zitat Pasulka PS, Bistrian BR, Benotti PN et al (1986) The risks of surgery in the obese. Ann Intern Med 104:540–546PubMedCrossRef Pasulka PS, Bistrian BR, Benotti PN et al (1986) The risks of surgery in the obese. Ann Intern Med 104:540–546PubMedCrossRef
7.
Zurück zum Zitat Murota-Kawano A, Ohya K, Sekine H (2008) Outpatient basis extracorporeal shock wave lithotripsy for ureter stones: efficacy of the third generation lithotripter as the first line treatment. Int J Urol 15:210–215PubMedCrossRef Murota-Kawano A, Ohya K, Sekine H (2008) Outpatient basis extracorporeal shock wave lithotripsy for ureter stones: efficacy of the third generation lithotripter as the first line treatment. Int J Urol 15:210–215PubMedCrossRef
8.
Zurück zum Zitat Delakas D, Karyotis I, Daskalopoulos G et al (2003) Independent predictors of failure of shockwave lithotripsy for ureteral stones employing a second-generation lithotripter. J Endourol 17:201–205PubMedCrossRef Delakas D, Karyotis I, Daskalopoulos G et al (2003) Independent predictors of failure of shockwave lithotripsy for ureteral stones employing a second-generation lithotripter. J Endourol 17:201–205PubMedCrossRef
9.
Zurück zum Zitat Muñoz RD, Tirolien PP, Belhamou S et al (2003) Treatment of reno-ureteral lithiasis with ESWL in obese patients. Apropos of 150 patients. Arch Esp Urol 56:933–938PubMed Muñoz RD, Tirolien PP, Belhamou S et al (2003) Treatment of reno-ureteral lithiasis with ESWL in obese patients. Apropos of 150 patients. Arch Esp Urol 56:933–938PubMed
11.
Zurück zum Zitat Binbay M, Yuruk E, Akman T et al (2010) Is there a difference in outcomes between digital and fiberoptic flexible ureterorenoscopy procedures? J Endourol 24:1929–1934PubMedCrossRef Binbay M, Yuruk E, Akman T et al (2010) Is there a difference in outcomes between digital and fiberoptic flexible ureterorenoscopy procedures? J Endourol 24:1929–1934PubMedCrossRef
12.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213PubMedCrossRef Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213PubMedCrossRef
14.
Zurück zum Zitat Semins MJ, Shore AD, Makary MA et al (2010) The association of increasing body mass index and kidney stone disease. J Urol 183:571–575PubMedCrossRef Semins MJ, Shore AD, Makary MA et al (2010) The association of increasing body mass index and kidney stone disease. J Urol 183:571–575PubMedCrossRef
15.
Zurück zum Zitat Delorme G, Huu Y, Liliaz J et al (2012) Ureterorenoscopy with Holmium- Yttrium- Aluminum- Garnet fragmentation is a safe and efficient tecnique for stone treatment in patients with body mass index superior to 30 kg/m2. J Endourol 26:239–243PubMedCrossRef Delorme G, Huu Y, Liliaz J et al (2012) Ureterorenoscopy with Holmium- Yttrium- Aluminum- Garnet fragmentation is a safe and efficient tecnique for stone treatment in patients with body mass index superior to 30 kg/m2. J Endourol 26:239–243PubMedCrossRef
16.
Zurück zum Zitat Thomas R, Cass AS (1993) Extracorporeal shock wave lithotripsy in morbidly obese patients. J Urol 150:30–32PubMed Thomas R, Cass AS (1993) Extracorporeal shock wave lithotripsy in morbidly obese patients. J Urol 150:30–32PubMed
17.
Zurück zum Zitat Pareek G, Armenakas NA, Fracchia JA (2003) Hounsfield units on computerized tomography predict stone-free rates after extra corporeal shock wave lithotripsy. J Urol 169:1679–1681PubMedCrossRef Pareek G, Armenakas NA, Fracchia JA (2003) Hounsfield units on computerized tomography predict stone-free rates after extra corporeal shock wave lithotripsy. J Urol 169:1679–1681PubMedCrossRef
18.
Zurück zum Zitat Carson CC 3rd, Danneberger JE, Weinerth JL (1988) Percutaneous lithotripsy in morbid obesity. J Urol 139:243–245PubMed Carson CC 3rd, Danneberger JE, Weinerth JL (1988) Percutaneous lithotripsy in morbid obesity. J Urol 139:243–245PubMed
19.
Zurück zum Zitat Faerber GJ, Goh M (1997) Percutaneous nephrolithotripsy in the morbidly obese patient. Tech Urol 3:89–95PubMed Faerber GJ, Goh M (1997) Percutaneous nephrolithotripsy in the morbidly obese patient. Tech Urol 3:89–95PubMed
20.
Zurück zum Zitat Pearle MS, Nakada SY, Womack JS, Kryger J (1998) Outcomes of contemporary percutaneous nephrostolithotomy in morbidly obese patients. J Urol 160:669–673PubMedCrossRef Pearle MS, Nakada SY, Womack JS, Kryger J (1998) Outcomes of contemporary percutaneous nephrostolithotomy in morbidly obese patients. J Urol 160:669–673PubMedCrossRef
21.
Zurück zum Zitat Fuller A, Razvi H, Denstedt JD, Nott L, Pearle M, Cauda F, Bolton D, Celia A, de la Rosette J (2012) CROES PCNL Study Group: the CROES Percutaneous Nephrolithotomy Global Study: The Influence of Body Mass Index on Outcome. J Urol 188:138–144PubMedCrossRef Fuller A, Razvi H, Denstedt JD, Nott L, Pearle M, Cauda F, Bolton D, Celia A, de la Rosette J (2012) CROES PCNL Study Group: the CROES Percutaneous Nephrolithotomy Global Study: The Influence of Body Mass Index on Outcome. J Urol 188:138–144PubMedCrossRef
22.
Zurück zum Zitat Karlsen SJ, Renkel J, Tahir AR et al (2007) Extracorporeal shockwave lithotripsy versus ureteroscopy for 5- to 10-mm stones in the proximal ureter: prospective effectiveness patient-preference trial. J Endourol 21:28–33PubMedCrossRef Karlsen SJ, Renkel J, Tahir AR et al (2007) Extracorporeal shockwave lithotripsy versus ureteroscopy for 5- to 10-mm stones in the proximal ureter: prospective effectiveness patient-preference trial. J Endourol 21:28–33PubMedCrossRef
23.
Zurück zum Zitat Dash A, Schuster TG, Hollenbeck BK et al (2002) Ureteroscopic treatment of renal calculi in morbidly obese patients: a stone matched comparison. Urology 60:393–397PubMedCrossRef Dash A, Schuster TG, Hollenbeck BK et al (2002) Ureteroscopic treatment of renal calculi in morbidly obese patients: a stone matched comparison. Urology 60:393–397PubMedCrossRef
24.
Zurück zum Zitat Andreoni C, Afane J, Olweny E et al (2001) Flexible ureteroscopic lithotripsy: first line therapy for proximal ureteral and renal calculi in the morbidly obese and superobese patient. J Endourol 15:493–498PubMedCrossRef Andreoni C, Afane J, Olweny E et al (2001) Flexible ureteroscopic lithotripsy: first line therapy for proximal ureteral and renal calculi in the morbidly obese and superobese patient. J Endourol 15:493–498PubMedCrossRef
25.
Zurück zum Zitat Bozkurt OF, Resorlu B, Yildiz Y, Can CE, Unsal A (2011) Retrograde intrarenal surgery versus percutaneous nephrolithotomy in the management of lower-pole renal stones with a diameter of 15 to 20 mm. J Endourol 25:1131–1135PubMedCrossRef Bozkurt OF, Resorlu B, Yildiz Y, Can CE, Unsal A (2011) Retrograde intrarenal surgery versus percutaneous nephrolithotomy in the management of lower-pole renal stones with a diameter of 15 to 20 mm. J Endourol 25:1131–1135PubMedCrossRef
26.
Zurück zum Zitat Chew BH, Zavaglia B, Paterson RF et al (2013) A multicenter comparison of the safety and effectiveness of ureteroscopic laser lithotripsy in obese and normal weight patients. J Endourol 27:710–714PubMedCrossRef Chew BH, Zavaglia B, Paterson RF et al (2013) A multicenter comparison of the safety and effectiveness of ureteroscopic laser lithotripsy in obese and normal weight patients. J Endourol 27:710–714PubMedCrossRef
27.
Zurück zum Zitat Caskurlu T, Atis G, Arikan O et al (2013) The impact of body mass index on the outcomes of retrograde intrarenal stone surgery. Urology 81:517–521PubMedCrossRef Caskurlu T, Atis G, Arikan O et al (2013) The impact of body mass index on the outcomes of retrograde intrarenal stone surgery. Urology 81:517–521PubMedCrossRef
28.
Zurück zum Zitat Bultitude MF, Tiptaft RC, Dasgupta P, Glass JM (2004) Treatment of urolithiasis in the morbidly obese. Obes Surg 14:300–304PubMedCrossRef Bultitude MF, Tiptaft RC, Dasgupta P, Glass JM (2004) Treatment of urolithiasis in the morbidly obese. Obes Surg 14:300–304PubMedCrossRef
29.
Zurück zum Zitat Akman T, Binbay M, Ugurlu M et al (2012) Outcomes of retrograde intrarenal surgery compared with percutaneous nephrolithotomy in elderly patients with moderate-size kidney stones: a matched-pair analysis. J Endourol 26:625–629PubMedCrossRef Akman T, Binbay M, Ugurlu M et al (2012) Outcomes of retrograde intrarenal surgery compared with percutaneous nephrolithotomy in elderly patients with moderate-size kidney stones: a matched-pair analysis. J Endourol 26:625–629PubMedCrossRef
Metadaten
Titel
Effect of the body mass index on outcomes of flexible ureterorenoscopy
verfasst von
Erhan Sari
Abdulkadir Tepeler
Emrah Yuruk
Berkan Resorlu
Tolga Akman
Murat Binbay
Abdullah Armagan
Ali Unsal
Ahmet Yaser Muslumanoglu
Publikationsdatum
01.11.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Urolithiasis / Ausgabe 6/2013
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-013-0590-7

Weitere Artikel der Ausgabe 6/2013

Urolithiasis 6/2013 Zur Ausgabe

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.